Y Nishiwaki

1.0k total citations
21 papers, 756 citations indexed

About

Y Nishiwaki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Y Nishiwaki has authored 21 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Y Nishiwaki's work include Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Y Nishiwaki is often cited by papers focused on Lung Cancer Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Y Nishiwaki collaborates with scholars based in Japan, United States and United Kingdom. Y Nishiwaki's co-authors include Kiyoyuki Furuse, Tetsutaro Tamura, H Ikegami, K Suemasu, Nagahiro Saijo, M Shimoyama, M. Fukuoka, Tomoyuki Yokose, Junji Yoshida and Kenji Suzuki and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, American Journal Of Pathology and British Journal of Cancer.

In The Last Decade

Y Nishiwaki

19 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Nishiwaki Japan 11 504 364 313 268 55 21 756
L Portalone Italy 11 418 0.8× 427 1.2× 60 0.2× 156 0.6× 84 1.5× 26 668
Xanthi Tsiafaki Greece 11 598 1.2× 571 1.6× 137 0.4× 161 0.6× 73 1.3× 36 762
Eagan Rt United States 15 400 0.8× 261 0.7× 152 0.5× 142 0.5× 61 1.1× 29 565
Masayuki Nishioka Japan 6 374 0.7× 359 1.0× 243 0.8× 331 1.2× 7 0.1× 16 732
G.S. Kho Netherlands 9 354 0.7× 317 0.9× 152 0.5× 81 0.3× 17 0.3× 15 525
Zsolt Pápai Hungary 7 513 1.0× 241 0.7× 322 1.0× 287 1.1× 43 0.8× 21 638
Marianna Macerelli Italy 12 284 0.6× 232 0.6× 136 0.4× 161 0.6× 79 1.4× 28 619
Monica Lencioni Italy 16 446 0.9× 214 0.6× 137 0.4× 140 0.5× 117 2.1× 51 791
Donald I. Twito United States 11 362 0.7× 233 0.6× 86 0.3× 122 0.5× 170 3.1× 13 603
Kvols Lk United States 10 420 0.8× 122 0.3× 341 1.1× 87 0.3× 19 0.3× 22 577

Countries citing papers authored by Y Nishiwaki

Since Specialization
Citations

This map shows the geographic impact of Y Nishiwaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Nishiwaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Nishiwaki more than expected).

Fields of papers citing papers by Y Nishiwaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Nishiwaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Nishiwaki. The network helps show where Y Nishiwaki may publish in the future.

Co-authorship network of co-authors of Y Nishiwaki

This figure shows the co-authorship network connecting the top 25 collaborators of Y Nishiwaki. A scholar is included among the top collaborators of Y Nishiwaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Nishiwaki. Y Nishiwaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawasaki, Hidenori, Tomoyuki Yokose, Junji Yoshida, et al.. (2001). Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. Journal of Surgical Oncology. 76(1). 53–57. 57 indexed citations
2.
Takamochi, Kazuya, Kenji Suzuki, Hidenori Kawasaki, et al.. (2001). Loss of Heterozygosity on Chromosomes 9q and 16p in Atypical Adenomatous Hyperplasia Concomitant with Adenocarcinoma of the Lung. American Journal Of Pathology. 159(5). 1941–1948. 57 indexed citations
3.
Sakai, Hiroshi, Shuichi Yoneda, Tomohide Tamura, et al.. (2001). A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients. Cancer Chemotherapy and Pharmacology. 48(6). 499–503. 14 indexed citations
4.
Kosugi, Chihiro, K Nagai, Hitoshi Kawasaki, et al.. (2000). [Surgical resection of lung cancer in a patient with von Willebrand's disease].. PubMed. 53(6). 464–7. 1 indexed citations
7.
Suzuki, Kenji, et al.. (1999). Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. Journal of Thoracic and Cardiovascular Surgery. 117(3). 593–598. 58 indexed citations
8.
Hosomi, Yukio, Yuichiro Ohe, Katsuaki Tanaka, et al.. (1999). Phase I Study of Cisplatin and Docetaxel Plus Mitomycin C in Patients with Metastatic Non-small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 29(11). 546–549. 2 indexed citations
9.
Tanaka, Katsuaki, Y. Shima, Yuichiro Ohe, et al.. (1999). Effect of Nebulized Morphine in Cancer Patients with Dyspnea: a Pilot Study. Japanese Journal of Clinical Oncology. 29(12). 600–603. 19 indexed citations
10.
Harada, Masako, et al.. (1999). Surgical Management of Primary Lung Cancer in an Elderly Patient with Preoperative Empyema. Japanese Journal of Clinical Oncology. 29(11). 571–575. 8 indexed citations
11.
Kawasaki, Hidenori, Junji Yoshida, Tomoyuki Yokose, et al.. (1998). Primary Unknown Cancer in Pulmonary Hilar Lymph Node with Spontaneous Transient Regression: Report of a Case. Japanese Journal of Clinical Oncology. 28(6). 405–409. 8 indexed citations
12.
Suzuki, Kenji, T. Ogura, Tomoyuki Yokose, et al.. (1998). Microsatellite instability in female non-small-cell lung cancer patients with familial clustering of malignancy. British Journal of Cancer. 77(6). 1003–1008. 10 indexed citations
13.
Suzuki, Kenji, Tsutomu Ogura, Tomoyuki Yokose, et al.. (1998). Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. International Journal of Cancer. 79(4). 384–389. 30 indexed citations
14.
Sekine, Ikuo, Tomoyuki Yokose, Tsutomu Ogura, et al.. (1997). Microsatellite Instability in Lung Cancer Patients 40 Years of Age or Younger. Japanese Journal of Cancer Research. 88(6). 559–563. 19 indexed citations
15.
Sekine, Ikuo, Shoichiro Tsugane, Kazuyuki Suzuki, et al.. (1997). Does smoking or family history influence the prognosis of patients with non-small cell lung cancer?. Oncology Reports. 4(6). 1221–7. 1 indexed citations
16.
Furuse, Kiyoyuki, Mitsumasa Ogawara, Masakichi Motomiya, et al.. (1994). A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Lung Cancer. 11(5-6). 385–391. 67 indexed citations
17.
Nakamura, Shintaro, et al.. (1993). A case of splenic penetration by a benign gastric ulcer.. PubMed. 88(11). 1964–6. 1 indexed citations
18.
Fukuoka, M., Kiyoyuki Furuse, Nagahiro Saijo, et al.. (1991). Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 83(12). 855–861. 341 indexed citations
19.
Kodama, Tetsuro, Hiroshi Nishiyama, & Y Nishiwaki. (1990). [Histology and prognosis in lung cancer treatment].. PubMed. 28(2). 216–24. 1 indexed citations
20.
Nishiyama, Hiroyuki, et al.. (1989). [Two cases of thymic carcinoid].. PubMed. 42(5). 404–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026